Chatham Capital Group Inc. Grows Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Chatham Capital Group Inc. raised its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 14.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 19,400 shares of the company’s stock after buying an additional 2,450 shares during the period. Chatham Capital Group Inc. owned about 0.13% of U.S. Physical Therapy worth $2,190,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of USPH. Vanguard Group Inc. grew its stake in shares of U.S. Physical Therapy by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock valued at $95,051,000 after buying an additional 17,156 shares during the period. Southernsun Asset Management LLC increased its stake in U.S. Physical Therapy by 5.9% in the fourth quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock valued at $44,634,000 after purchasing an additional 26,758 shares during the last quarter. Semanteon Capital Management LP purchased a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $767,000. RK Capital Management LLC purchased a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $6,166,000. Finally, Schroder Investment Management Group grew its position in shares of U.S. Physical Therapy by 12.1% during the third quarter. Schroder Investment Management Group now owns 384,936 shares of the company’s stock worth $35,310,000 after acquiring an additional 41,414 shares during the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $105.46, for a total value of $181,813.04. Following the transaction, the chief operating officer now directly owns 6,970 shares of the company’s stock, valued at approximately $735,056.20. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $105.46, for a total transaction of $181,813.04. Following the sale, the chief operating officer now directly owns 6,970 shares of the company’s stock, valued at approximately $735,056.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Christopher J. Reading sold 2,900 shares of the company’s stock in a transaction on Thursday, May 30th. The stock was sold at an average price of $100.26, for a total value of $290,754.00. Following the transaction, the chief executive officer now owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The disclosure for this sale can be found here. Insiders sold 10,724 shares of company stock worth $1,114,385 in the last 90 days. 1.70% of the stock is owned by company insiders.

Analyst Ratings Changes

USPH has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research report on Wednesday, March 13th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $122.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $125.67.

U.S. Physical Therapy Price Performance

USPH stock traded down $0.70 during trading on Friday, hitting $92.42. The stock had a trading volume of 318,260 shares, compared to its average volume of 116,619. The company’s 50 day moving average price is $100.29 and its two-hundred day moving average price is $99.84. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $124.11. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 75.14, a price-to-earnings-growth ratio of 3.59 and a beta of 1.40. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.16 and a current ratio of 2.16.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07). The business had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The firm’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.59 EPS. On average, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd were issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.90%. The ex-dividend date was Wednesday, May 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.